Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Sees Opportunity In Foreign Income Repatriation Bill

This article was originally published in The Tan Sheet

Executive Summary

Legislation pending in Congress to allow repatriation of overseas income is an "interesting opportunity," Abbott Chief Financial Officer Thomas Freyman said during an Oct. 9 conference call

You may also be interested in...



Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out

Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year

Merck Sees Chance To “Repatriate” Cash To U.S.; GSK Wants To Ship Out

Merck sees an opportunity to bring back cash to the U.S. should a tax change allowing companies to "repatriate" holdings at foreign subsidiaries be enacted by Congress this year

Foreign Cash Repatriation Bill Can Pass If Tied To Jobs, Breaux Tells PhRMA

Legislation to allow pharmaceutical companies to transfer cash held by overseas affiliates to the U.S. has a chance to pass Congress this year - if the bill ensures that proceeds are devoted to the creation of new jobs, Sen. John Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting April 3 in Palm Beach, Fla

Topics

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel